Interestingly, STING expression and signaling can be reconstituted in glioma cell lines via exposure to decitabine, a DNA hypomethylating agent that has been shown to enhance immune recognition and killing of glioma-initiating cells (92). The gene discussed is STING1; the disease is central nervous system cancer.